Changes in risk factors and tumor node metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin

Metabolism: Clinical and Experimental

Volumn 60, Issue 5, 2011, Pages 604-608

  Karga, Helen ^a   Giagourta, Irene ^a   Papaioannou, Garyphallia ^a   Doumouchtsis, Konstantinos ^a   Polymeris, Antonis ^a   Thanou, Stavroula ^a   Papamichael, Konstantinos ^a   Zerva, Cherry ^a  

^a ALEXANDRA HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN;

ADULT; ARTICLE; CALCITONIN BLOOD LEVEL; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTROLLED STUDY; DISTANT METASTASIS; ECHOGRAPHY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; THYROID MEDULLARY CARCINOMA; TUMOR VOLUME;

CALCITONIN; CARCINOMA, MEDULLARY; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 79955044183     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.06.004     Document Type: Article

References (27)

1. Ball W.D. Medullary thyroid cancer: monitor and therapy Endocrinol Metab Clin North Am 36 2007 823 883
2. Roman S., Rong L., and Sosa J.A. Prognosis of medullary thyroid carcinoma Cancer 107 2006 2134 2142
3. Kebebew E., Ituarte P.H., and Siperstein A.E. Medullary thyroid carcinoma. Clinical characteristics, treatment, prognostic factors, and a comparison of staging systems Cancer 88 2000 1139 1148 (Pubitemid 30127676)
4. Wada N., Nakayama H., and Suganuma N. Prognostic value of the sixth edition AJCC/UICC TNM classification for differentiated thyroid carcinoma with extrathyroid extension J Clin Endocrinol Metab 92 2007 215 218 (Pubitemid 46067534)
5. Miccoli P., Minuto M.N., and Ugolini C. Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer Endocr Relat Cancer 14 2007 1099 1105 (Pubitemid 351252441)
6. de Groot J.W., Plukker J.T., and Wolffenbuttel B.H. Determinants of life expectancy in medullary thyroid cancer: age does not matter Clin Endocrinol 65 2006 729 736 (Pubitemid 44772352)
7. Hanna F.W.F., Cunningham R.T., and Ardill J.E.S. Prognostic factors in medullary carcinoma of the thyroid Endocr Relat Cancer 5 1998 49 53 (Pubitemid 28168190)
8. Barbet J., Camion L., and Kraeber-Bodere F. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling times in patients with medullary thyroid carcinoma J Clin Endocrinol Metab 90 2005 6077 6084 (Pubitemid 41606528)
9. Elisei R., Bottici V., and Luchetti F. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders J Clin Endocrinol Metab 89 2004 163 168 (Pubitemid 38183876)
10. Wierhapper H., Raber W., and Bieglmayer C. Routine measurement of plasma calcitonin in nodular thyroid diseases J Clin Endocrinol Metab 82 1997 1589 1593 (Pubitemid 27200439)
11. Hodak S., and Burman K. The calcitonin conundrum-is it time for routine measurement of serum calcitonin in patients with thyroid nodules? J Clin Endocrinol Metab 89 2004 511 514 (Pubitemid 38269850)
12. Castro R., and Gharib H. Continuing controversies in the management of thyroid nodules Ann Intern Med 142 2005 926 931 (Pubitemid 40791808)
13. Papini E., Guglielmi R., and Biancini A. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color Doppler features J Clin Endocrinol Μetab 87 2002 1941 1946 (Pubitemid 34521470)
14. Schwrtz K.E., Wolfsen A.R., and Forster B. Calcitonin in nonthyroidal cancer J Clin Endocrinol Metab 49 1979 438 444 (Pubitemid 10188192)
15. Biddinger P.W., Brennan M.F., Rosen P.P., and Symptomatic C. Cell hyperplasia associated with chronic lymphocytic thyroiditis Am J Surg Pathol 15 1991 599 604
16. Laboratory support for the diagnosis and monitoring of thyroid disease. Calcitonin (CT) and RET proto-oncogene measurement Thyroid 13 2003 68 79
17. Pantazi H., and Papapetrou P.D. Calcitonin levels are similar in goitrous euthyroid patients with or without thyroid antibodies, as well as in hypothyroid patients Eur J Endocrinol 138 1998 530 535 (Pubitemid 28238188)
18. Modigliani E., Cohen R., and Campos J.M. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients Clin Endocrinol 48 1998 265 273 (Pubitemid 28137636)
19. Borget I., De Pouvourville G., and Schlumberer M. Calcitonin determination in patients with nodular thyroid disease J Clin Endocrinol Metab 92 2007 425 427
20. Deftos L. Should serum calcitonin be routinely measured in patients with thyroid nodules-will the law answer before endocrinologists do? J Clin Endocrinol Metab 89 2004 4768 4769
21. Cohen R., Campos J.M., and Salaun C. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma J Clin Endocrinol Metab 85 2000 919 922 (Pubitemid 32273687)
22. Gulben K., Berberroglu U., and Boyabatti M. Prognostic factors for sporadic medullary thyroid carcinoma World J Surg 30 2006 84 90 (Pubitemid 43081618)
23. Al-Rawl M., and Wheeler M. Medullary carcinoma-update and present management controversies Ann R Coll Surg Engl 88 2006 433 438 (Pubitemid 44390349)
24. Roman S., Mehta P., and Sosa J.A. Medullary thyroid cancer: early detection and novel treatments Curr Opin Oncol 21 2008 5 10
25. Pacini F., Fontanelli M., and Fugazzola L. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma J Clin Endocrinol Metab 78 1994 826 829 (Pubitemid 24118072)
26. Karga H.J., Karayianni M.K., and Linos D.A. Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma Eur J Endocrinol 139 1998 410 415 (Pubitemid 28494085)
27. Costante G., Meringolo D., and Durante C. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules J Clin Endocrinol Metab 92 2007 450 455